Mark J. Alles

Insider Reports History

Entity
Individual
Location
C/O Celgene Corporation, 86 Morris Avenue, Summit, NJ
Signature
/s/ Todd Rosenthal, as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mark J. Alles:

Stock Role Class Num Shares Value Price $ Report Date Ownership
BIOMARIN PHARMACEUTICAL INC Director Common Stock 15.1K $1.45M $96.38 May 23, 2023 Direct
Syros Pharmaceuticals, Inc. Director Common Stock 3.67K $16.2K $4.42 Sep 16, 2023 Direct
Syros Pharmaceuticals, Inc. Director Restricted Stock Units 5.33K $11.8K $2.22 Sep 16, 2023 Direct
Turning Point Therapeutics, Inc. Director Common Stock 0 $76.00 Aug 17, 2022 Direct
Turning Point Therapeutics, Inc. Director Stock Option (right to buy) 0 Aug 17, 2022 Direct

Insider Reports Filed by Mark J. Alles

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SYRS Syros Pharmaceuticals, Inc. Sep 16, 2023 2 $0 4 Sep 19, 2023 Director
SYRS Syros Pharmaceuticals, Inc. Jun 1, 2023 2 $0 4 Jun 2, 2023 Director
BMRN BIOMARIN PHARMACEUTICAL INC May 23, 2023 1 $0 4 May 24, 2023 Director
BMRN BIOMARIN PHARMACEUTICAL INC Oct 31, 2022 1 $314K 4 Nov 2, 2022 Director
SYRS Syros Pharmaceuticals, Inc. Sep 16, 2022 2 $0 4 Sep 19, 2022 Director
TPTX Turning Point Therapeutics, Inc. Aug 17, 2022 3 -$152K 4 Aug 17, 2022 Director
SYRS Syros Pharmaceuticals, Inc. Jun 1, 2022 1 $0 4 Jun 2, 2022 Director
BMRN BIOMARIN PHARMACEUTICAL INC May 24, 2022 1 $0 4 May 26, 2022 Director
BMRN BIOMARIN PHARMACEUTICAL INC Jan 3, 2022 1 $0 4 Jan 5, 2022 Director
BMRN BIOMARIN PHARMACEUTICAL INC Jan 1, 2022 0 $0 3 Jan 5, 2022 Director
TPTX Turning Point Therapeutics, Inc. Jun 21, 2021 1 $163K 4 Jun 21, 2021 Director
SYRS Syros Pharmaceuticals, Inc. Jun 8, 2021 1 $0 4 Jun 10, 2021 Director
TPTX Turning Point Therapeutics, Inc. Jun 2, 2021 1 $0 4 Jun 4, 2021 Director
TPTX Turning Point Therapeutics, Inc. May 24, 2021 1 $0 4 May 26, 2021 Director
TPTX Turning Point Therapeutics, Inc. May 24, 2021 0 $0 3 May 26, 2021 Director